

Jeffrey Schmidt
MedTech Advisor
Innovation · Digital · AI
Bio
I have spent more than two decades in MedTech, leading R&D, innovation, digital, AI, software, and services businesses at GE HealthCare, BD, Carl Zeiss Meditec, and Welch Allyn. Before that, I worked in enterprise technology and aerospace at Peak Technologies, Sun Microsystems, McDonnell Douglas, and the U.S. Air Force.Much of my career has been spent helping businesses create or regain growth when existing innovation strategies, portfolios, and operating models were no longer delivering. My work has included rebuilding portfolios and teams, accelerating development, creating digital businesses, integrating acquisitions, and redirecting investment toward higher-return opportunities.The results have been consistent: development cycles cut by more than half, growth accelerated to multiples of market rates, launch predictability improved, R&D intensity reduced while output expanded, and digital businesses created that generated both new revenue and pull-through for core portfolios.Today I advise leadership teams, investors, and governments on turning technology and innovation investment into growth.
Selected leadership experience
GE HealthCare · 2023–2025
Chief Innovation Officer, Advanced Visualization Solutions ($5B+ business)
Chief Technology Officer, Image Guided Therapies ($2B+ business)
BD · 2021–2023
VP R&D, Vascular Access Devices ($2B+ business)
VP Front-End Innovation, Medication Delivery Solutions ($4.5B business)
Carl Zeiss Meditec · 2014–2021
VP R&D, Ophthalmic Diagnostics ($500M+ business)
Head of AI, company-wide
Welch Allyn · 2003–2014
VP International R&D
GM, Global Services ($30M business in a $700M+ company)
Earlier
Technology, digital, and operational leadership at Peak Technologies, Sun Microsystems, McDonnell Douglas, and the U.S. Air Force
Advisory and public sector
Singapore MedTech Ecosystem · 2026–2028
Member of the A*STAR MedTech International Advisory Panel, advising Singapore’s lead public sector R&D agency on aligning MedTech development with national priorities and global market needs
Singapore Biomedical Ecosystem · 2010–2014
Chair, Industry Chapter Advisory Board, Biomedical Engineering Society
Member, Bioengineering Departmental Consultative Committee, National University of Singapore
Selection committee member, President's Technology Award
Guest lecturer, Singapore-Stanford Biodesign
Patents and technical contributions
US 12,303,197 B2 (2025) · US 10,918,278 B2 (2021) · US 10,028,658 B2 (2018)Four systems-architecting heuristics cited in The Art of Systems Architecting (Maier & Rechtin)
Summit Park Advisory LLC · Park City, Utah · [email protected]